NEW YORK (GenomeWeb News) – EMD Millipore said today that its Discovery and Development Solutions business has received CLIA certification for its contract research lab located in St. Louis.

The Billerica, Mass.-based division of Germany's Merck KGaA said that the Discovery and Development Solutions business develops and performs immunoassays on human and animal samples and offers biomarker analysis for an array of therapeutic applications including diabetes, infection, neurodegenerative disease, osteoporosis, and cancer.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.

An opinion piece at Bloomberg discusses China's stance on genomic research.

Genetic ancestry testing can affect a person's sense of identity, the New York Times Magazine writes.

Nebula Genomics is launching its genome sequencing service for free for people who provide certain information about themselves, the Boston Globe reports.